May 21, 2024

Integrating Omics into Functional Biomarkers of Type 1 Diabetes

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

S. Alice Long1 and Peter S. Linsley2 1Center for Translational Immunology, Benaroya Research Institute, Seattle, Washington 98101, USA 2Center for Systems Immunology, Benaroya Research Institute, Seattle, Washington 98101, USA Correspondence: alongatbenaroyaresearch. org; plinsleyatbenaroyaresearch. org

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Long et al. (Tue,) studied this question.

synapsesocial.com/papers/68e69222b6db643587618c12 https://doi.org/https://doi.org/10.1101/cshperspect.a041602

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Identification of a B cell signature associated with renal transplant tolerance in humans2010 · 669 citations
2DNA Methylation–Based Assessment of Cell Composition in Human Pancreas and Islets2024 · 6 citations
3Donor-derived Cell-free DNA Shows High Sensitivity for the Diagnosis of Pancreas Graft Rejection in Simultaneous Pancreas-kidney Transplantation2022 · 42 citations
4The methylome and cell-free DNA: current applications in medicine and pediatric disease2023 · 29 citations
5Plasma protein biomarkers predict the development of persistent autoantibodies and type 1 diabetes 6 months prior to the onset of autoimmunity2023 · 46 citations

Preguntar a la IA

Me gusta

Guardar